Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 18 10:05AM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-61.43 Insider Own10.17% Shs Outstand0.56M Perf Week-5.98%
Market Cap0.32M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.51M Perf Month-82.48%
Income-9.74M PEG- EPS next Q- Inst Own12.47% Short Float43.22% Perf Quarter-87.07%
Sales0.00M P/S- EPS this Y- Inst Trans- Short Ratio0.66 Perf Half Y-92.35%
Book/sh10.02 P/B0.06 EPS next Y- ROA-122.06% Short Interest0.22M Perf Year-98.67%
Cash/sh4.75 P/C0.12 EPS next 5Y- ROE-155.50% 52W Range0.53 - 111.84 Perf YTD-94.17%
Dividend Est.- P/FCF- EPS past 5Y-62.82% ROI-274.49% 52W High-99.49% Beta0.80
Dividend TTM- Quick Ratio2.26 Sales past 5Y-25.00% Gross Margin- 52W Low7.32% ATR (14)0.30
Dividend Ex-Date- Current Ratio2.26 EPS Y/Y TTM20.96% Oper. Margin0.00% RSI (14)27.79 Volatility9.08% 18.22%
Employees10 Debt/Eq0.10 Sales Y/Y TTM-100.00% Profit Margin- Recom3.00 Target Price256.00
Option/ShortNo / Yes LT Debt/Eq0.05 EPS Q/Q60.41% Payout- Rel Volume2.48 Prev Close0.56
Sales Surprise- EPS Surprise-155.21% Sales Q/Q- Earnings- Avg Volume332.14K Price0.57
SMA20-56.06% SMA50-81.00% SMA200-95.34% Trades Volume111,534 Change1.57%
Jun-28-24 11:32AM
Jun-27-24 08:58AM
Jun-26-24 08:00AM
Jun-17-24 08:00AM
07:40AM Loading…
Mar-28-24 11:53PM
Jan-02-24 05:58PM
Dec-28-23 08:00AM
Dec-27-23 09:00AM
Nov-09-23 04:05PM
Aug-28-23 07:59AM
Aug-25-23 08:00AM
Aug-16-23 07:00AM
Aug-10-23 04:05PM
08:30AM Loading…
Jul-24-23 08:30AM
Jul-21-23 07:00AM
May-31-23 06:36AM
May-19-23 07:00AM
May-10-23 07:30AM
Mar-20-23 04:15PM
Feb-16-23 08:00AM
Nov-13-22 08:01AM
Nov-09-22 08:00AM
Aug-30-22 04:05PM
Aug-24-22 06:09AM
Aug-16-22 07:30AM
Jul-27-22 07:30AM
Jul-26-22 04:30PM
Jul-06-22 07:30AM
07:30AM Loading…
Jun-09-22 07:30AM
May-05-22 11:21AM
Apr-20-22 04:10PM
Mar-28-22 07:00AM
Mar-24-22 07:00AM
Mar-17-22 06:53AM
Mar-10-22 07:00AM
Jan-31-22 07:00AM
Jan-13-22 11:29AM
Jan-11-22 04:19PM
Jan-05-22 08:15AM
Dec-16-21 09:11AM
Dec-07-21 07:25AM
Nov-10-21 08:15AM
Bluejay Diagnostics, Inc. operates as a diagnostic company. It develops and markets minimally-invasive Point-of-Care diagnostics tests and devices that provide patients and providers with access to affordable and timely healthcare. It focus is on the infectious disease, inflammation, and oncology markets. The company was founded by Svetlana Dey and Dey Indraneil on March 20, 2015 and is headquartered in Acton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dey IndranilPresident and CEODec 13 '23Buy3.275001,63528,526Dec 14 04:16 PM
Dey SvetlanaDirectorDec 13 '23Buy3.075001,5351,500Dec 14 04:17 PM